Liangfang Zhang
Overview
Explore the profile of Liangfang Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
276
Citations
14809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krishnan N, Zhou J, Mohapatra A, Ventura C, Duan Y, Lee J, et al.
Adv Mater
. 2025 Feb;
:e2501616.
PMID: 39989146
Cancer vaccines are a promising immunotherapeutic modality that function by training the immune system to recognize and destroy malignant cells. As tumor-specific and tumor-associated antigens generally cannot be identified until...
2.
Sun L, Feng K, Bai D, Yu Y, Shen W, Zhang J, et al.
Biomaterials
. 2025 Feb;
318:123188.
PMID: 39954312
Drug overdose is a pressing global public health challenge, with current detoxification treatments often lacking the broad-spectrum efficacy needed for emergency applications. Inspired by the unique advantages of cell membrane-derived...
3.
Feng K, Zhang J, Shen W, Leng T, Zhou Z, Yu Y, et al.
Langmuir
. 2025 Jan;
41(4):2124-2140.
PMID: 39862147
Poisoning by organophosphate (OP) nerve agents remains a pressing global threat due to their extensive use in chemical warfare agents and pesticides, potentially causing high morbidity and mortality worldwide. This...
4.
Li Z, Guo Z, Zhang F, Sun L, Luan H, Fang Z, et al.
Nat Commun
. 2025 Jan;
16(1):666.
PMID: 39809831
Amidst the rising prevalence of respiratory diseases, the importance of effective lung treatment modalities is more critical than ever. However, current drug delivery systems face significant limitations that impede their...
5.
Noh I, Guo Z, Wang R, Zhu A, Krishnan N, Mohapatra A, et al.
J Control Release
. 2024 Dec;
378:145-152.
PMID: 39657891
The effective delivery of chemotherapeutic drugs to tumor sites is critical for cancer treatment and remains a significant challenge. The advent of nanomedicine has provided additional avenues for altering the...
6.
Nandhakumar P, Sun L, Li Z, Cheung C, Nguyen L, Ding S, et al.
Anal Chem
. 2024 Dec;
96(49):19812-19821.
PMID: 39620950
The growing need for reliable and rapid insulin testing to enhance glycemic management has spurred intensive exploration of new insulin-binding bioreceptors and innovative biosensing platforms for detecting this hormone, along...
7.
Yu Y, Silva-Ayala D, Zhou Z, Peng Y, Fang R, Gao W, et al.
Nano Lett
. 2024 Nov;
24(47):15136-15141.
PMID: 39535430
Cellular nanoparticles (CNPs), which refer to nanoparticles coated with natural cell membranes, are promising for neutralizing pathological agents. Here, we use CNPs as a medical countermeasure against the infection of...
8.
Kai M, Shen W, Wang D, Yu Y, Zhang J, Sun L, et al.
Adv Healthc Mater
. 2024 Oct;
14(2):e2403539.
PMID: 39460406
Aptamers are single-stranded oligonucleotides that fold into defined architectures for specific target binding. In this study, aptamers are selected that specifically bind to small-molecule neurotoxins and encapsulate them into cell...
9.
Kim J, Uchiyama S, Gong H, Stream A, Zhang L, Nizet V
Engineering (Beijing)
. 2024 Oct;
7(8):1149-1156.
PMID: 39449819
is a leading human pathogen capable of producing severe invasive infections such as bacteremia, sepsis and endocarditis with high morbidity and mortality, exacerbated by expanding antibiotic-resistance exemplified by methicillin-resistant strains...
10.
Zhang J, Feng K, Shen W, Gao W, Zhang L
ACS Nano
. 2024 Oct;
18(44):30211-30223.
PMID: 39441568
Cellular nanoparticles (CNPs), fabricated by coating natural cell membranes onto nanoparticle cores, have been widely used to replicate cellular functions for various therapeutic applications. Specifically, CNPs act as cell decoys,...